Literature DB >> 4078866

Osmotic fragility test in heterozygotes for alpha and beta thalassaemia.

L Maccioni, A Cao.   

Abstract

This study shows that the combination of heterozygous beta thalassaemia and deletion heterozygous (-alpha/alpha alpha) or homozygous (-alpha/-alpha) alpha+ thalassaemia may result in the production of erythrocytes which have normal mean volume and haemoglobinisation but decreased osmotic fragility. Based on this finding and previous studies, which have shown that beta thalassaemia screening by the osmotic fragility test may miss a significant proportion of beta thalassaemia heterozygotes, we conclude that beta thalassaemia screening in a population in which both alpha and beta thalassaemia are prevalent should combine the one tube osmotic fragility test with electronic measurement of red blood cell indices in the initial screening process.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4078866      PMCID: PMC1049481          DOI: 10.1136/jmg.22.5.374

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  7 in total

1.  Types of thalassaemia-trait carriers as revealed by a study of their incidence in Greece.

Authors:  B MALAMOS; P FESSAS; G STAMATOYANNOPOULOS
Journal:  Br J Haematol       Date:  1962-01       Impact factor: 6.998

2.  Beta 0 thalassemia trait in Sardinia.

Authors:  R Galanello; M A Melis; R Ruggeri; M Addis; M T Scalas; L Maccioni; M Furbetta; A Angius; T Tuveri; A Cao
Journal:  Hemoglobin       Date:  1979       Impact factor: 0.849

3.  Screening for thalassemia trait by electronic measurement of mean corpuscular volume.

Authors:  H A Pearson; R T O'Brien; S McIntosh
Journal:  N Engl J Med       Date:  1973-02-15       Impact factor: 91.245

4.  Control of homozygous beta-thalassemia by carrier screening and antenatal diagnosis in Sardinians.

Authors:  A Cao; L Pintus; U Lecca; G Olla; P Cossu; C Rosatelli; R Galanello
Journal:  Clin Genet       Date:  1984-07       Impact factor: 4.438

5.  The interaction of alpha thalassaemia with heterozygous beta thalassaemia.

Authors:  E Kanavakis; J S Wainscoat; W G Wood; D J Weatherall; A Cao; M Furbetta; R Galanello; D Georgiou; T Sophocleous
Journal:  Br J Haematol       Date:  1982-11       Impact factor: 6.998

6.  Prenatal diagnosis of beta-thalassemia. Detection of a single nucleotide mutation in DNA.

Authors:  M Pirastu; Y W Kan; A Cao; B J Conner; R L Teplitz; R B Wallace
Journal:  N Engl J Med       Date:  1983-08-04       Impact factor: 91.245

7.  Phenotypic effect of heterozygous alpha and beta 0-thalassemia interaction.

Authors:  M A Melis; M Pirastu; R Galanello; M Furbetta; T Tuveri; A Cao
Journal:  Blood       Date:  1983-07       Impact factor: 22.113

  7 in total
  2 in total

1.  A transgenic mouse model expressing exclusively human hemoglobin E: indications of a mild oxidative stress.

Authors:  Qiuying Chen; Mary E Fabry; Anne C Rybicki; Sandra M Suzuka; Tatiana C Balazs; Zipora Etzion; Kitty de Jong; Edna K Akoto; Joseph E Canterino; Dhananjay K Kaul; Frans A Kuypers; David Lefer; Eric E Bouhassira; Rhoda Elison Hirsch
Journal:  Blood Cells Mol Dis       Date:  2012-01-18       Impact factor: 3.039

Review 2.  Epistasis and the sensitivity of phenotypic screens for beta thalassaemia.

Authors:  Bridget S Penman; Sunetra Gupta; David J Weatherall
Journal:  Br J Haematol       Date:  2014-12-17       Impact factor: 6.998

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.